Hepatitis C. Chronic hepatitis C may affect three hundred million persons worldwide.1 Of these a significant number will progress to cirrhosis and thereafter to hepatocellular carcinoma.2 No vaccine currently exists for hepatitis C. Moreover, many individuals who become infected are not aware that they are infected. As a result, some do not seek treatment until irreversible liver damage has occurred. Accordingly, effective treatment remains essential.
Appears in 2 contracts
Sources: License Agreement (Intarcia Therapeutics, Inc), License Agreement (Intarcia Therapeutics, Inc)